Cargando…
Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities
Animal models are crucial for the study of severe infectious diseases, which is essential for determining their pathogenesis and the development of vaccines and drugs. Animal experiments involving risk grade 3 agents such as SARS CoV, HIV, M.tb, H7N9, and Brucella must be conducted in an Animal Bios...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148666/ https://www.ncbi.nlm.nih.gov/pubmed/32501433 http://dx.doi.org/10.1016/j.jobb.2018.12.011 |
_version_ | 1783520640576258048 |
---|---|
author | Guo, Ming Wang, Yong Liu, Jinbiao Huang, Zhixiang Li, Xiangdong |
author_facet | Guo, Ming Wang, Yong Liu, Jinbiao Huang, Zhixiang Li, Xiangdong |
author_sort | Guo, Ming |
collection | PubMed |
description | Animal models are crucial for the study of severe infectious diseases, which is essential for determining their pathogenesis and the development of vaccines and drugs. Animal experiments involving risk grade 3 agents such as SARS CoV, HIV, M.tb, H7N9, and Brucella must be conducted in an Animal Biosafety Level 3 (ABSL-3) facility. Because of the in vivo work, the biosafety risk in ABSL-3 facilities is higher than that in BSL-3 facilities. Undoubtedly, management practices must be strengthened to ensure biosafety in the ABSL-3 facility. Meanwhile, we cannot ignore the reliable scientific results obtained from animal experiments conducted in ABSL-3 laboratories. It is of great practical significance to study the overall biosafety concepts that can increase the scientific data quality. Based on the management of animal experiments in the ABSL-3 Laboratory of Wuhan University, combined with relevant international and domestic literature, we indicate the main safety issues and factors affecting animal experiment results at ABSL-3 facilities. Based on these issues, management practices regarding animal experiments in ABSL-3 facilities are proposed, which take into account both biosafety and scientifically sound data. |
format | Online Article Text |
id | pubmed-7148666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Published by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71486662020-04-13 Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities Guo, Ming Wang, Yong Liu, Jinbiao Huang, Zhixiang Li, Xiangdong J Biosaf Biosecur Article Animal models are crucial for the study of severe infectious diseases, which is essential for determining their pathogenesis and the development of vaccines and drugs. Animal experiments involving risk grade 3 agents such as SARS CoV, HIV, M.tb, H7N9, and Brucella must be conducted in an Animal Biosafety Level 3 (ABSL-3) facility. Because of the in vivo work, the biosafety risk in ABSL-3 facilities is higher than that in BSL-3 facilities. Undoubtedly, management practices must be strengthened to ensure biosafety in the ABSL-3 facility. Meanwhile, we cannot ignore the reliable scientific results obtained from animal experiments conducted in ABSL-3 laboratories. It is of great practical significance to study the overall biosafety concepts that can increase the scientific data quality. Based on the management of animal experiments in the ABSL-3 Laboratory of Wuhan University, combined with relevant international and domestic literature, we indicate the main safety issues and factors affecting animal experiment results at ABSL-3 facilities. Based on these issues, management practices regarding animal experiments in ABSL-3 facilities are proposed, which take into account both biosafety and scientifically sound data. Published by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. 2019-03 2019-02-20 /pmc/articles/PMC7148666/ /pubmed/32501433 http://dx.doi.org/10.1016/j.jobb.2018.12.011 Text en © 2019 Published by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Guo, Ming Wang, Yong Liu, Jinbiao Huang, Zhixiang Li, Xiangdong Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities |
title | Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities |
title_full | Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities |
title_fullStr | Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities |
title_full_unstemmed | Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities |
title_short | Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities |
title_sort | biosafety and data quality considerations for animal experiments with highly infectious agents at absl-3 facilities |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148666/ https://www.ncbi.nlm.nih.gov/pubmed/32501433 http://dx.doi.org/10.1016/j.jobb.2018.12.011 |
work_keys_str_mv | AT guoming biosafetyanddataqualityconsiderationsforanimalexperimentswithhighlyinfectiousagentsatabsl3facilities AT wangyong biosafetyanddataqualityconsiderationsforanimalexperimentswithhighlyinfectiousagentsatabsl3facilities AT liujinbiao biosafetyanddataqualityconsiderationsforanimalexperimentswithhighlyinfectiousagentsatabsl3facilities AT huangzhixiang biosafetyanddataqualityconsiderationsforanimalexperimentswithhighlyinfectiousagentsatabsl3facilities AT lixiangdong biosafetyanddataqualityconsiderationsforanimalexperimentswithhighlyinfectiousagentsatabsl3facilities |